(FM) Neurología

2021

1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

   Revista de Neurologia

2. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

   Journal of Parkinson's Disease, Vol. 11, Núm. 1, pp. 187-198

3. Atención inicial en el absceso cerebral

   Manual de urgencias 5ª ed (Editorial Médica Panamericana), pp. 549-554

4. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation (Scientific Reports, (2019), 9, 1, (14172), 10.1038/s41598-019-50627-w)

   Scientific Reports

5. Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm

   Advances in Therapy, Vol. 38, Núm. 8, pp. 4442-4460

6. Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: A case series study

   Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 9, pp. 927-931

7. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

   International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

8. Blood pressure and risk of cognitive impairment: The role of vascular disease in neurodegeneration

   Brain Sciences, Vol. 11, Núm. 3

9. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

   Journal of Headache and Pain, Vol. 22, Núm. 1

10. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7

11. COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study

    Epilepsy and Behavior, Vol. 125

12. Caso 17. neurología

    Manual de casos con pacientes estandarizados para el ECOE (Editorial Médica Panamericana), pp. 56-57

13. Caso 28. Evaluación del paciente mayor

    Manual de casos con pacientes estandarizados para el ECOE (Editorial Médica Panamericana), pp. 88-89

14. Caso 32. Urgencia en Atención Primaria

    Manual de casos con pacientes estandarizados para el ECOE (Editorial Médica Panamericana), pp. 97-98

15. Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 2, pp. 285-297

16. Degree of compliance with treatment at three months in migraine patients

    Revista de Neurologia, Vol. 72, Núm. 11, pp. 377-383

17. Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

    Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820

18. Development, equivalence study, and normative data of version B of the Spanish-language Free and Cued Selective Reminding Test

    Neurologia, Vol. 36, Núm. 5, pp. 353-360

19. Dissociable effects of age and Parkinson's disease on instruction-based learning

    Brain Communications, Vol. 3, Núm. 3

20. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240